MesoPher as a Maintenance Treatment after Chemotherapy,
Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
📰 Nk Cell News
Nk Cell News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nk Cell. Real-time updates on events, politics, business and more.
Innate Pharma Announces Abstracts Selected for ESMO Congress 2023
MARSEILLE, France, October 16, 2023--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the following presentations will be presented at the European Society for Medical Oncology (ESMO) Congress 2023, taking place October 20-24 in Madrid, Spain.
Fabrice Barlesi Villejuif Fayette Lyon Monalizumab Astrazeneca Rachel Galot Woluwe Saint Lambert Henry Wheeler French Financial Markets Authority
Source: yahoo.com
Ozempic, Wegovy could boost cancer-killing cells, small study suggests
A study of 20 people with obesity hinted at the possibility for semaglutide — the active ingredient in Type 2 diabetes drug Ozempic and weight-loss drug Wegovy — to increase the functionality of natural killer cells, which destroy cancerous cells.
Source: beckershospitalreview.com
LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits
LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment kits for immunology research.
United States Martin Pieprzyk Levitasbio Early Access Program Levitasbio Inc Menlo Park Leviselect Immune Cell Kits
Source: businesswireindia.com
Cellular Immunotherapy (CAR T Cell Therapy, Dendritic Cell
Dublin, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Cellular Immunotherapy Market Size, Share & Trends Analysis Report by Therapy Type (CAR T Cell...
United States Adicet Bio Inc National Cancer Institute Bristol Myers Squibb Company Gilead Sciences Inc Cancer Research
Source: globenewswire.com